<DOC>
	<DOCNO>NCT00899873</DOCNO>
	<brief_summary>RATIONALE : Studying sample cell laboratory patient cancer may help identify biomarkers related cancer . It may also help doctor learn patient respond treatment . PURPOSE : This laboratory study analyze sample cell patient chronic lymphocytic leukemia treat clinical trial ECOG-2997 .</brief_summary>
	<brief_title>Biomarkers Samples From Patients With Chronic Lymphocytic Leukemia Treated Clinical Trial ECOG-2997</brief_title>
	<detailed_description>OBJECTIVES : - To analyze expression variety informative molecule use unique high-resolution flow cytometric immunophenotyping technology sample patient chronic lymphocytic leukemia enrol clinical trial ECOG-2997 . OUTLINE : Cell sample analyze follow prognostic biomarkers : ZAP-70 , phospho-Syk , phospho-GSK-3β , phospho-Akt , phospho-ZAP-70 , cyclin D1 , cyclin D2 , p21cip1 , phospho-ReIA , IkappaBα , Bax , Mcl-1 , PTEN , phospho-Erk1/2 , phospho-MEK1/2 . Biomarker signal amplify use enzymatic amplification stain obtain high resolution detection cell-surface marker leukemic cell . Biomarker expression level measure use fluorescence activate cell sort analysis . Relationships clinical outcome , standard flow cytometric analysis , cytogenetic study , high resolution immunophenotyping also assess .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Lymphocytic , Chronic , B-Cell</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Stored freeze viable cell patient chronic lymphocytic leukemia treat clinical trial ECOG2997 PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>chronic lymphocytic leukemia</keyword>
</DOC>